| oct-2009 | Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required | Pascual, Ana M; Téllez, Neus; Casanova, Bonaventura; Perez-Sempere, Angel; Bosca, Isabel; Mallada, Javier; Fernández, Pascual; Montalbán, Xavier; Belenguer, Antonio; Abellán, Inmaculada; Magraner, María José; Coret, Francisco; Sanz, Miguel A; Montalbán, Xavier | |